Cholelitholytic agents.
D000818:Animals; D001646:Bile / Q000187:drug effects / Q000378:metabolism; D001647:Bile Acids and Salts / Q000008:administration & dosage; D002210:Caprylates; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage / Q000009:adverse effects; D002769:Cholelithiasis / Q000188:drug therapy*; D019826:Cholic Acid; D002793:Cholic Acids / Q000008:administration & dosage; D003135:Common Bile Duct; D053138:Cyclohexenes; D004359:Drug Therapy, Combination; D004492:Edetic Acid / Q000008:administration & dosage; D042882:Gallstones / Q000188:drug therapy; D005989:Glycerides / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007440:Intubation; D000077222:Limonene; D050356:Lipid Metabolism; D012008:Recurrence; D012997:Solvents / Q000008:administration & dosage; D013729:Terpenes / Q000008:administration & dosage; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
D001647:Bile Acids and Salts; D002210:Caprylates; D002793:Cholic Acids; D053138:Cyclohexenes; D005989:Glycerides; D012997:Solvents; D013729:Terpenes; D002635:Chenodeoxycholic Acid; D014580:Ursodeoxycholic Acid; D006493:Heparin; D004492:Edetic Acid; D000077222:Limonene; D019826:Cholic Acid; C025343:monooctanoin